Welcome to our dedicated page for JACK NATHAN MED news (Ticker: $JNHMF), a resource for investors and traders seeking the latest updates and insights on JACK NATHAN MED stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect JACK NATHAN MED's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of JACK NATHAN MED's position in the market.
Jack Nathan Health reported a 24% growth in revenue for the fiscal year 2024, reaching $19.1 million. The company expanded to 245 locations globally, with a focus on Canada and Mexico. The partnership with Walmart drove robust financial outcomes, leading to an increase in revenue. The company opened 9 new clinics in Canada and experienced significant growth in Mexico. Operating expenses decreased, resulting in a smaller net loss compared to the previous year. The balance sheet showed an increase in cash and total assets, with total liabilities also increasing. The company had 87,099,159 common shares outstanding as of January 31, 2024.
